Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study to Describe Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France and Its Use in Routine Clinical Practice

NCT02347865 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02347865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02347865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study to Describe Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France and Its Use in Routine Clinical Practice
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
June 16, 2015
Completion date
September 27, 2018
Enrollment
777 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post menopausal osteoporosis